Successful management of a planned pregnancy in severe congenital thrombotic thrombocytopaenic purpura: The Upshaw-Schulman syndrome

Transfusion Medicine

Volumn 21, Issue 3, 2011, Pages 211-213

  Richter, J ^a   Strandberg, K ^b   Lindblom, A ^a   Strevens, H ^a   Karpman, D ^c   Wide Swensson, D ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b University and Regional Laboratories Region Skåne ^*  (Sweden)

^c LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; LOW MOLECULAR WEIGHT HEPARIN; TINZAPARIN; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ADULT; CASE REPORT; CESAREAN SECTION; FEMALE; GENE MUTATION; HUMAN; LETTER; LOW DRUG DOSE; PLASMAPHERESIS; PREECLAMPSIA; PREGNANCY; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOTIC THROMBOCYTOPENIC PURPURA; UPSHAW SCHULMAN SYNDROME;

ADULT; FAMILY PLANNING SERVICES; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PURPURA, THROMBOTIC THROMBOCYTOPENIC; TREATMENT OUTCOME;

EID: 79955096952     PISSN: 09587578     EISSN: 13653148     Source Type: Journal    
DOI: 10.1111/j.1365-3148.2010.01067.x     Document Type: Letter

References (12)

1. Barbot, J., Costa, E., Guerra, M. et al. (2001) Ten years of prophylactic treatment with fresh-frozen plasma in a child with chronic relapsing thrombotic thrombocytopenic purpura as a result of a congenital deficiency of von Willebrand factor-cleaving protease. British Journal of Haematology, 113, 649-651.
2. Bramham, K., Hilton, R., Horsfield, C., McDonald, V., Camilleri R. & Hunt, B.J. (2010) ADAMTS-13 deficiency: can it cause chronic renal failure? Nephrology, Dialysis, Transplantation [Epub ahead of print].
3. Donadelli, R., Banterla, F., Galbusera, M. et al. (2006) In-vitro and in-vivo consequences of mutations in the von Willebrand factor cleaving protease ADAMTS13 in thrombotic thrombocytopenic purpura. Thrombosis and Haemostasis, 96, 454-464.
4. Ezra, Y., Rose, M. & Eldor, A. (1996) Therapy and prevention of thrombotic thrombocytopenic purpura during pregnancy: a clinical study of 16 pregnancies. American Journal of Hematology, 51, 1-6.
5. Fujimura, Y., Matsumoto, M., Kokame, K. et al. (2009) Pregnancy-induced thrombocytopenia and TTP, and the risk of fetal death, in Upshaw-Schulman syndrome: a series of 15 pregnancies in 9 genotyped patients. British Journal of Haematology, 144, 742-754.
6. Furlan, M., Robles, R., Morselli, B., Sandoz, P. & Lammle, B. (1999) Recovery and half-life of von Willebrand factor-cleaving protease after plasma therapy in patients with thrombotic thrombocytopenic purpura. Thrombosis and Haemostasis, 81, 8-13.
7. Kokame, K., Nobe, Y., Kokubo, Y., Okayama, A. & Miyata, T. (2005) FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay. British Journal of Haematology, 129, 93-100.
8. Levy, G.G., Nichols, W.C., Lian, E.C. et al. (2001) Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature, 413, 488-494.
9. Nguyen, L., Terrell, D.R., Duvall, D., Vesely, S.K. & George, J.N. (2009) Complications of plasma exchange in patients treated for thrombotic thrombocytopenic purpura. IV. An additional study of 43 consecutive patients, 2005 to 2008. Transfusion, 49, 392-394.
10. Proia, A., Paesano, R., Torcia, F. et al. (2002) Thrombotic thrombocytopenic purpura and pregnancy: a case report and a review of the literature. Annals of Hematology, 81, 210-214.
11. Scully, M., Starke, R., Lee, R., Mackie, I., Machin, S. & Cohen, H. (2006) Successful management of pregnancy in women with a history of thrombotic thrombocytopaenic purpura. Blood Coagulation & Fibrinolysis, 17, 459-463.
12. Tzafettas, J., Petropoulos, P., Psarra, A., Delkos, D., Papaloukas, C., Giannoulis, H., Kalogiros, G. & Gkoutzioulis, F. (2005) Early antiplatelet and antithrombotic therapy in patients with a history of recurrent miscarriages of known and unknown aetiology. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 120, 22-26.